In this issue:
Modified pathologic nodal classification system for cutaneous melanoma
Crossover and rechallenge with pembrolizumab in recurrent patients after complete resection of high-risk stage III melanoma
ctDNA in metastatic melanoma
Pre-IMID is associated with improved survival and increased toxicity in melanoma patients who receive ICIs
Association between melanoma detected during routine skin checks and mortality
Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survival
FDG-PET to predict long-term outcome from anti-PD1 therapy in metastatic melanoma
More SNB for thin melanomas after transition to AJCC 8th edition do not increase positivity rate
Antitumour activity of ipilimumab or BRAFi ± MEKi after pembrolizumab in patients with advanced melanoma
Surgical management of SNB positive melanoma in the post-MSLT2 era
Please login below to download this issue (PDF)